Therapeutic Potential of Epigallocatechin-3-Gallate in Cancer: A Systematic Review of Human Cancer
Abstract
In an effort to prevent and manage various types of cancer, the following study seeks to synthesize the results of various clinical trials on the efficacy and safety of the use of epigallocatechin 3-gallate. The systematic review method was employed in the following study as an effort to review the results of various clinical trials on the therapeutic response and safety of the use of EGCG in cancer patients, strictly following the PRISMA 2020 criteria. From the results of the search in the five online databases, a total of 293 articles were identified, from which seven clinical trials published between 2014 and 2024 were identified. The results of the clinical trials on the efficacy and safety of the use of EGCG in cancer patients showed that EGCG has the potential to reduce the levels of PSA in various groups of patients with prostate cancer, as well as reduce the occurrence of acute radiation esophagitis in patients with advanced lung cancer, although the results were not statistically significant. Although EGCG has an excellent safety profile with no serious side effects reported, its definitive therapeutic efficacy remains unclear, necessitating randomized controlled clinical trials to clarify its clinical relevance and health implications.
Keywords: Cancer, Clinical Trial, Epigallocatechin-3-Gallate (EGCG), Public Health, Systematic Review.
Full Text:
PDFReferences
Abdulridha, M. K., Al-Marzoqi, A. H., Al-awsi, G. R. L., Mubarak, S. M. H., Heidarifard, M., & Ghasemian, A. (2020/). Anticancer Effects of Herbal Medicine Compounds and Novel Formulations: a Literature Review. Journal of Gastrointestinal Cancer, 51(3), 765–773. https://doi.org/10.1007/s12029-020-00385-0
Almatroodi, S. A., Almatroudi, A., Khan, A. A., Alhumaydhi, F. A., Alsahli, M. A., & Rahmani, A. H. (2020/). Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. Molecules, 25(14), 3146. https://doi.org/10.3390/molecules25143146
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., Dhanjal, J. K., Dewanjee, S., Vallamkondu, J., & Pérez de la Lastra, J. M. (2023/). Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes & Diseases, 10(4), 1367–1401. https://doi.org/10.1016/j.gendis.2022.02.007
Banerjee, S., Nau, S., Hochwald, S. N., Xie, H., & Zhang, J. (2023/). Anticancer properties and mechanisms of botanical derivatives. Phytomedicine Plus, 3(1), 100396. https://doi.org/10.1016/j.phyplu.2022.100396
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024/). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. https://doi.org/10.3322/caac.21834
Brown, J. S., Amend, S. R., Austin, R. H., Gatenby, R. A., Hammarlund, E. U., & Pienta, K. J. (2023/). Updating the Definition of Cancer. Molecular Cancer Research, 21(11), 1142–1147. https://doi.org/10.1158/1541-7786.MCR-23-0411
Capasso, L., De Masi, L., Sirignano, C., Maresca, V., Basile, A., Nebbioso, A., Rigano, D., & Bontempo, P. (2025/). Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential. Molecules, 30(3), 654. https://doi.org/10.3390/molecules30030654
Catalano, A., Iacopetta, D., Ceramella, J., Scumaci, D., Giuzio, F., Saturnino, C., Aquaro, S., Rosano, C., & Sinicropi, M. S. (2022/). Multidrug resistance (MDR): A widespread phenomenon in pharmacological therapies. Molecules, 27(3), 616. https://doi.org/10.3390/molecules27030616
Chen, X., Tong, R., Liu, B., Liu, H., Feng, X., Ding, S., Lei, Q., Tang, G., Wu, J., & Fang, W. (2020/). Duo of (–)-epigallocatechin-3-gallate and doxorubicin loaded by polydopamine coating ZIF-8 in the regulation of autophagy for chemo-photothermal synergistic therapy. Biomaterials Science, 8(5), 1380–1393. https://doi.org/10.1039/C9BM01614G
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M., & Pinzaru, I. (2021/). Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules, 26(4), 1109. https://doi.org/10.3390/molecules26041109
DeVita, V. T., Rosenberg, S. A., & Lawrence, T. S. (2022/). Cancer: Principles and Practice of Oncology, 12th Edition. Wolters Kluwer Health. https://books.google.co.id/books?id=JvGKEAAAQBAJ
Hanahan, D. (2022/). Hallmarks of Cancer: New Dimensions. Cancer Discovery, 12(1), 31–46. https://doi.org/10.1158/2159-8290.CD-21-1059
Hao, Q., Wu, Y., Vadgama, J. V., & Wang, P. (2022/). Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies. Biomolecules, 12(9), 1306. https://doi.org/10.3390/biom12091306
Henning, S. M., Wang, P., Lee, R.-P., Trang, A., Husari, G., Yang, J., Grojean, E. M., Ly, A., Hsu, M., Heber, D., Grogan, T., Li, Z., & Aronson, W. J. (2020/). Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer. Food & Function, 11(5), 4114–4122. https://doi.org/10.1039/D0FO00565G
Kocarnik, J. M., Compton, K., Dean, F. E., Fu, W., Gaw, B. L., Harvey, J. D., Henrikson, H. J., Lu, D., Pennini, A., Xu, R., Ababneh, E., Abbasi-Kangevari, M., Abbastabar, H., Abd-Elsalam, S. M., Abdoli, A., Abedi, A., Abidi, H., Abolhassani, H., Adedeji, I. A., … Force, L. M. (2022/). Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019. JAMA Oncology, 8(3), 420. https://doi.org/10.1001/jamaoncol.2021.6987
Kumar, N. B., Pow-Sang, J., Egan, K. M., Spiess, P. E., Dickinson, S., Salup, R., Helal, M., McLarty, J., Williams, C. R., Schreiber, F., Parnes, H. L., Sebti, S., Kazi, A., Kang, L., Quinn, G., Smith, T., Yue, B., Diaz, K., Chornokur, G., … Schell, M. J. (2015/). Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prevention Research, 8(10), 879–887. https://doi.org/10.1158/1940-6207.CAPR-14-0324
Lane, J. A., Er, V., Avery, K. N. L., Horwood, J., Cantwell, M., Caro, G. P., Crozier, A., Smith, G. D., Donovan, J. L., Down, L., Hamdy, F. C., Gillatt, D., Holly, J., Macefield, R., Moody, H., Neal, D. E., Walsh, E., Martin, R. M., & Metcalfe, C. (2018/). ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer. Cancer Prevention Research, 11(11), 687–696. https://doi.org/10.1158/1940-6207.CAPR-18-0147
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., Johnson, S. C., Browne, A. J., Chipeta, M. G., Fell, F., Hackett, S., Haines-Woodhouse, G., Kashef Hamadani, B. H., Kumaran, E. A. P., McManigal, B., … Naghavi, M. (2022/). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0
Nierengarten, M. B. (2024/). Global cancer statistics 2022. Cancer, 130(15), 2568–2568. https://doi.org/10.1002/cncr.35444
Niu, L., Luo, Y., Xie, W., Wang, C., & Liu, Z. (2026/). Dietary (−)-Epigallocatechin Gallate (EGCG): State-of-the-Art Advances in Bioactivities, Bioavailability Enhancement Strategies, and Applications in Nutrition and Health. Nutrients, 18(2), 317. https://doi.org/10.3390/nu18020317
Panigrahi, A., Mohanty, S. S., Behera, P., Dandsena, R. S., Sahu, P., & Pati, S. (2025/). Implementation research on common cancers (lung, breast, and colorectal) in Asia – a systematic review. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1671298
Ren, B., Kwah, M. X.-Y., Liu, C., Ma, Z., Shanmugam, M. K., Ding, L., Xiang, X., Ho, P. C.-L., Wang, L., Ong, P. S., & Goh, B. C. (2021/). Resveratrol for cancer therapy: Challenges and future perspectives. Cancer Letters, 515, 63–72. https://doi.org/10.1016/j.canlet.2021.05.001
Rusli, R., Christeven, R., & Faruk, M. (2023/). Cancer incidence and mortality in a tertiary hospital in Indonesia: An 18-year data review. Ethiopian Journal of Health Sciences, 33(3). https://doi.org/10.4314/ejhs.v33i3.15
Sehgal, A., Bhat, M. A., Dogra, D., Rawat, S., & Dhatwalia, S. K. (2023/). EGCG: The antioxidant powerhouse in lung cancer management and chemotherapy enhancement. Advances in Redox Research, 9, 100085. https://doi.org/10.1016/j.arres.2023.100085
Sharifi-Zahabi, E., Hajizadeh-Sharafabad, F., Abdollahzad, H., Dehnad, A., & Shidfar, F. (2021/). The effect of green tea on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine, 57, 102659. https://doi.org/10.1016/j.ctim.2020.102659
Siddiqui, I. A., Sanna, V., Ahmad, N., Sechi, M., & Mukhtar, H. (2015/). Resveratrol nanoformulation for cancer prevention and therapy. Annals of the New York Academy of Sciences, 1348(1), 20–31. https://doi.org/10.1111/nyas.12811
Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025/). Cancer statistics, 2025. CA: A Cancer Journal for Clinicians, 75(1), 10–45. https://doi.org/10.3322/caac.21871
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021/). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Syalsabila, D. P., & Manafe, C. J. W. (2024/). Potential of Epigallocatechin-3-Gallate and 5-Fluorouracil Combination in Colorectal Cancer Therapy: Literature Review. Jurnal Biologi Tropis, 24(1b), 327–334. https://doi.org/10.29303/jbt.v24i1b.7950
Zhang, C.-H., Wang, J.-X., Cai, M.-L., Shao, R., Liu, H., & Zhao, W.-L. (2019/). The roles and mechanisms of G3BP1 in tumour promotion. Journal of Drug Targeting, 27(3), 300–305. https://doi.org/10.1080/1061186X.2018.1523415
Zhang, C., Zhang, W., Wu, Y., Peng, B., Tian, C., Luan, F., Sun, W., Zhuang, X., & Zhao, L. (2022/). Sensitive and Facile HCOOH Fluorescence Sensor Based on Highly Active Ir Complexes’ Catalytic Transfer Hydrogen Reaction. Molecules, 27(21), 7431. https://doi.org/10.3390/molecules27217431
Zhang, Z., Garzotto, M., Beer, T. M., Thuillier, P., Lieberman, S., Mori, M., Stoller, W. A., Farris, P. E., & Shannon, J. (2016/). Effects of ω -3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial. Nutrition and Cancer, 68(8), 1309–1319. https://doi.org/10.1080/01635581.2016.1224365
Zhao, H., Jia, L., Chen, G., Li, X., Meng, X., Zhao, X., Xing, L., & Zhu, W. (2019/). A prospective, three-arm, randomized trial of EGCG for preventing radiation-induced esophagitis in lung cancer patients receiving radiotherapy. Radiotherapy and Oncology, 137, 186–191. https://doi.org/10.1016/j.radonc.2019.02.022
Zhao, H., Xie, P., Li, X., Zhu, W., Sun, X., Sun, X., Chen, X., Xing, L., & Yu, J. (2015/). A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer. Radiotherapy and Oncology, 114(3), 351–356. https://doi.org/10.1016/j.radonc.2015.02.014
Zhao, J., Blayney, A., Liu, X., Gandy, L., Jin, W., Yan, L., Ha, J.-H., Canning, A. J., Connelly, M., Yang, C., Liu, X., Xiao, Y., Cosgrove, M. S., Solmaz, S. R., Zhang, Y., Ban, D., Chen, J., Loh, S. N., & Wang, C. (2021/). EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction. Nature Communications, 12(1), 986. https://doi.org/10.1038/s41467-021-21258-5
Zhu, W., Zhao, Y., Zhang, S., Li, X., Xing, L., Zhao, H., & Yu, J. (2021/). Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.686950
DOI: http://dx.doi.org/10.30829/contagion.v8i1.26945
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Denny Satria Utama, Krisna Murti, Irfanuddin Irfanuddin
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
